Page last updated: 2024-08-17

nad and Cardiac Toxicity

nad has been researched along with Cardiac Toxicity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Podyacheva, E; Toropova, Y1
Li, WD; Mao, S; Yang, HB; Yuan, W1
Han, J; Kim, HK; Nifantiev, NE; Yashunsky, DV; Yoon, CS1
Brockman, J; Cao, T; Fan, GC; Ni, R; Peng, T; Wang, G; Zhang, L; Zhang, Y; Zheng, D; Zheng, M; Zhong, H1

Reviews

1 review(s) available for nad and Cardiac Toxicity

ArticleYear
Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects.
    Nutrients, 2021, Sep-28, Volume: 13, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Disease Management; Disease Models, Animal; Disease Susceptibility; Doxorubicin; Humans; Metabolic Networks and Pathways; NAD; Niacinamide; Oxidative Stress; Pyridinium Compounds; Signal Transduction; Sirtuins

2021

Other Studies

3 other study(ies) available for nad and Cardiac Toxicity

ArticleYear
Selenium Supplementation Protects Against Arsenic-Trioxide-Induced Cardiotoxicity Via Reducing Oxidative Stress and Inflammation Through Increasing NAD
    Biological trace element research, 2023, Volume: 201, Issue:8

    Topics: Animals; Apoptosis; Arsenic; Arsenic Trioxide; Cardiotoxicity; Dietary Supplements; Inflammation; Mice; NAD; Oxidative Stress; Selenium

2023
Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 165

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotoxicity; Doxorubicin; Humans; Mice; Mitochondria; Myocytes, Cardiac; NAD

2023
Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
    Clinical science (London, England : 1979), 2019, 07-15, Volume: 133, Issue:13

    Topics: Animals; Antioxidants; Autophagy; Cardiotoxicity; Cells, Cultured; Cytoprotection; Disease Models, Animal; Doxorubicin; Heart Diseases; Hydrogen-Ion Concentration; Lysosomes; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; NAD; Niacinamide; Oxidative Stress; Pyridinium Compounds; Sirtuin 1

2019